Stockscreener 앱 받기
11.17
0.45%
0.05
전일 마감가:
$11.12
열려 있는:
$11.185
하루 거래량:
4.43M
Relative Volume:
0.80
시가총액:
$2.23B
수익:
$3.68B
순이익/손실:
$-627.00M
주가수익비율:
-3.5486
EPS:
-3.1477
순현금흐름:
$104.00M
1주 성능:
+2.57%
1개월 성능:
-16.45%
6개월 성능:
-23.91%
1년 성능:
-21.89%
1일 변동 폭
$10.89
$11.22
1주일 범위
$10.61
$11.29
52주 변동 폭
$9.405
$14.86
덴츠플라이 Stock (XRAY) Company Profile
명칭
Dentsply Sirona Inc
전화
844-546-3722
주소
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Compare XRAY vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XRAY
Dentsply Sirona Inc
|
11.17 | 2.15B | 3.68B | -627.00M | 104.00M | -3.1477 |
ISRG
Intuitive Surgical Inc
|
376.86 | 132.30B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
188.11 | 51.11B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
72.06 | 35.25B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
240.10 | 32.95B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.03 | 28.58B | 29.14B | 1.07B | 1.05B | 1.1956 |
덴츠플라이 Stock (XRAY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Sell |
| 2026-02-19 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-11-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2025-04-15 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-13 | 다운그레이드 | Needham | Buy → Hold |
| 2025-02-14 | 개시 | Wells Fargo | Equal Weight |
| 2025-01-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-01-07 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-11-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-10-25 | 재확인 | Needham | Buy |
| 2024-08-20 | 재확인 | Needham | Buy |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2023-11-16 | 개시 | Needham | Buy |
| 2023-11-10 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | 업그레이드 | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | 다운그레이드 | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | 업그레이드 | UBS | Neutral → Buy |
| 2022-04-20 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-04-19 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | 개시 | Morgan Stanley | Overweight |
| 2021-10-01 | 재개 | Credit Suisse | Outperform |
| 2021-08-09 | 재확인 | H.C. Wainwright | Neutral |
| 2021-08-06 | 재확인 | Barrington Research | Outperform |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-03-02 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | 재확인 | H.C. Wainwright | Neutral |
| 2021-01-05 | 재확인 | H.C. Wainwright | Neutral |
| 2020-12-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2020-11-17 | 다운그레이드 | Barclays | Equal Weight → Underweight |
| 2020-11-09 | 재확인 | H.C. Wainwright | Neutral |
| 2020-10-22 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-08-10 | 재확인 | H.C. Wainwright | Neutral |
| 2020-06-16 | 개시 | Piper Sandler | Overweight |
| 2020-06-15 | 재확인 | H.C. Wainwright | Neutral |
| 2020-05-27 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-05-11 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | 재확인 | H.C. Wainwright | Neutral |
| 2020-04-08 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | 다운그레이드 | Goldman | Buy → Neutral |
| 2020-04-02 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | 재확인 | H.C. Wainwright | Neutral |
| 2020-02-19 | 재확인 | Stifel | Buy |
| 2019-12-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2019-08-02 | 업그레이드 | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | 개시 | Evercore ISI | In-line |
| 2019-07-09 | 재확인 | H.C. Wainwright | Neutral |
| 2019-05-30 | 개시 | Wolfe Research | Peer Perform |
모두보기
덴츠플라이 주식(XRAY)의 최신 뉴스
Edmond DE Rothschild Holding S.A. Purchases Shares of 4,503,300 DENTSPLY SIRONA Inc. $XRAY - MarketBeat
More than 13 million Americans face incontinence challenges; Wellspect launches a home system - Stock Titan
DENTSPLY SIRONA Inc. $XRAY Shares Purchased by Bank of America Corp DE - MarketBeat
Royal Bank of Canada Raises Holdings in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona (XRAY) Q2 2026 Earnings Call Transcript - AOL.com
The 5 Most Interesting Analyst Questions From Dentsply Sirona’s Q2 Earnings Call - Yahoo Finance
DENTSPLY Sirona Inc (XRAY) News, Articles, Events & Latest Updates - Stocktwits
Dentsply Sirona (XRAY): Southpoint reports 7M-share, 3.5% ownership in 13G/A - Stock Titan
Is DENTSPLY SIRONA’s (XRAY) Steady Buyback and Reaffirmed Outlook Reframing Its Risk‑Reward Profile? - simplywall.st
DENTSPLY SIRONA (XRAY) gains AQR Capital as 5.22% beneficial owner - Stock Titan
DS World Las Vegas 2026 connects clinical and laboratory education - Dental Tribune US
DENTSPLY SIRONA (XRAY) CFO awarded 104,200 stock options and 24,014 RSUs - Stock Titan
Pacer Advisors Inc. Has $266,000 Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
DENTSPLY SIRONA (XRAY) SVP Frohning reports 802 tax-withheld shares - Stock Titan
XRAY Q2 Deep Dive: Turnaround Progress Slowed by Market and Segment Headwinds - Yahoo Finance
DENTSPLY SIRONA (XRAY): Navigating Challenges With A 17.66% Potential Upside - DirectorsTalk Interviews
Why Dentsply Sirona (XRAY) Stock Is Trading Lower Today - Yahoo Finance
Dentsply Sirona Earnings: Weak Recovery Momentum Unchanged as Soft Volume Weighs on Results - Morningstar
Empowered Funds LLC Grows Stake in DENTSPLY SIRONA Inc. $XRAY - MarketBeat
Dentsply Sirona (XRAY) Stock Drops As Revenue Weakens Despite Profit Rebound - Sahm
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Form 8K Dentsply Sirona Inc For: 7 August By Investing.com - Investing.com Nigeria
DENTSPLY SIRONA Q2 Earnings Call Highlights - MarketBeat
1% Undervalued? DENTSPLY SIRONA (XRAY) As Earnings Test Its Recovery Story - Yahoo Finance
Dentsply Sirona Reports $898 Million in Net Sales for Second Quarter 2026 - Orthodontic Products
Dentsply's Full Recovery Timeline Looks Uncertain as Tough Market and Competition Put Pressure - Morningstar
XRAY Stock Falls Despite Q2 Earnings Beat, Wellspect Drives Sales - Yahoo Finance
DENTSPLY SIRONA (NASDAQ:XRAY) Trading Down 8.4%Here's What Happened - MarketBeat
A Quick Look at Today's Ratings for Dentsply Sirona(XRAY.US), With a Forecast Between $9 to $15 - Moomoo
DENTSPLY SIRONA Inc. Q2 2026 Earnings Call Summary - finance.yahoo.com
DENTSPLY SIRONA Inc. Stock 12‑Month Price Target Raised to $13.7, Implies 4% Upside - TradingView
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q2 Earnings - Yahoo Finance
DENTSPLY SIRONA Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:XRAY) 2026-08-06 - Seeking Alpha
Earnings call transcript: DENTSPLY Sirona posts slight q2 2026 revenue beat, shares fall - Investing.com
DENTSPLY SIRONA (NASDAQ:XRAY) Issues Earnings Results - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Releases FY 2026 Earnings Guidance - marketbeat.com
Dentsply International (XRAY) Beats Q2 Earnings and Revenue Estimates - finance.yahoo.com
Transcript : DENTSPLY SIRONA Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com
DENTSPLY SIRONA Inc. 2026: Revenue $898M, EPS $0.18— 10-Q Summary - TradingView
DENTSPLY SIRONA Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
[10-Q] DENTSPLY SIRONA Inc. Quarterly Earnings Report - Stock Titan
Tranche Update on DENTSPLY SIRONA Inc.'s Equity Buyback Plan announced on March 16, 2005. - marketscreener.com
DENTSPLY SIRONA ($XRAY) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Dentsply Sirona (NASDAQ:XRAY) Beats Q2 CY2026 Sales Expectations - Yahoo Finance
Earnings Flash (XRAY) DENTSPLY SIRONA Inc. Reports Q2 Revenue $898.0M, vs. FactSet Est of $889.9M - marketscreener.com
DENTSPLY SIRONA (XRAY): First Eagle discloses 851,347-share position in 13G/A - Stock Titan
Earnings Flash (XRAY) DENTSPLY SIRONA Inc. Posts Q2 Adjusted EPS $0.52 per Share - marketscreener.com
Dentsply Sirona Reports Second Quarter 2026 Results - marketscreener.com
BRIEF-Dentsply Sirona Q2 Revenue USD 898 Million Vs. IBES Estimate USD 889.8 Million - TradingView
Dentsply Sirona investors brace for earnings amid Medline threat By Investing.com - Investing.com Nigeria
Expanded Medline Sinclair Tech Distribution in Canada Could Be A Game Changer For DENTSPLY SIRONA (XRAY) - simplywall.st
덴츠플라이 (XRAY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
덴츠플라이 주식 (XRAY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MCKEON BRIAN P | Director |
Jun 12 '26 |
Buy |
10.12 |
10,000 |
101,200 |
10,000 |
| Gladden Brian T | Director |
Jun 15 '26 |
Buy |
10.02 |
9,985 |
100,000 |
61,849 |
| HOLDEN BETSY D | Director |
Jun 11 '26 |
Buy |
9.88 |
10,086 |
99,692 |
87,528 |
| Barber Michael J | Director |
Jun 11 '26 |
Buy |
9.88 |
15,175 |
150,005 |
55,943 |
| LUCIER GREGORY T | Director |
Mar 09 '26 |
Buy |
12.45 |
15,000 |
186,675 |
65,000 |
| Forbes James D | Director |
Mar 09 '26 |
Buy |
12.48 |
5,000 |
62,400 |
10,000 |
| LUCIER GREGORY T | Director |
Mar 02 '26 |
Buy |
14.24 |
27,555 |
392,521 |
27,555 |
| LUCIER GREGORY T | Director |
Mar 03 '26 |
Buy |
14.03 |
22,445 |
314,858 |
50,000 |
1.40%
0.50%
자본화:
|
볼륨(24시간):